履歴 業績 日本語[Japanese] / 英語[English]
| 履 歴 書 氏名 高見 博
経歴:
賞:
認定医・指導医：
国内学会役員：
外国学会のメンバー:
雑誌・機関誌編集:
学会・研究会の会長：
主な著書の編集 英文著書編集 日本の臨床・基礎医学のレベルは先進諸国と比べ低いとは思わないが、それらを体系づけた英文の成書は少ない。多くは若手,中堅の医師,研究者により、外国留学の延長として、学位論文として、昇進の手段として執筆していることが多い。
和文著書編集
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
. 1) Takami H, Yamaguchi K, Abe K, Adachi I, Arai S, Kameya T, Yamachika K, Tashiro M, Nakagawa Y, and Abe O. A case of Zollinger-Ellison syndrome whose pancreatic tumor produced multiple hormones and a review of 48 cases reported in the Japanese literature. Jpn J Clin Oncol. 1978;8(1):75-89. . 2) Busch H, Ballal NR, Busch RK, Samal B, Choi YC, Davis FM, Kunkle HM, Nall K, Parker D, Rao MS, Rothblum LI, Takami H. Hierarchical controls of nucleolar synthetic functions. Differentiation and Development. New York, Academic Press, pp 187-209, 1978 . 3) Takami H, Busch H. Two-dimensional gel electrophoretic comparison of proteins of nuclear fractions of normal liver and Novikoff hepatoma. Cancer Res. 1979;39(2):507-518. . 4) Takami H, Busch FN, Morris HP, Busch H. Comparison of salt-extractable nuclear proteins of regenerating liver, fetal liver, and Morris hepatoma 9618A and 3924A. Cancer Res. 1979;39(6):2096-2105. . 5) Busch H, Takami H, Davis FM, Busch RK, Wu BC, Spohn WH, Raju KS. Nonhistone nuclear proteins of cancer cells. In: Fox M (ed), Advances in medical oncology, research and education, vol.4, Biological basis for cancer diagnosis, 1st ed. Oxford and New York, Pergamon Press, pp 21-26, 1979 . 6) Takami H, Romsdahl MM, Nishioka K. Polyamines in blood-cells as a cancer marker. Lancet. 1979;2:912-913. . 7) Takami H, Nishioka K. Raised polyamines in erythrocytes from melanoma-bearing mice and patients with solid tumors. Br J Cancer. 1980;41(5):751-756. . 8) Takami H, Abe O. Alterations of cytoplasmic proteins in rat hepatomas during the administration of chemical carcinogen. Keio J Med. 1980;29(1):9-17. . 9) Nishioka K, Takami H, Noyes RD, Babcock GF. CloudmanS-91 melanoma colony assay in the lungs of mice and profiles of the biochemical tumor markers tyrosinase and polyamines. In: Seiji M (eds), Pigment cell 1981:Phenotypic expression in pigment cells. Tokyo, University of Tokyo Press, pp 617-621, 1981 . 10) Mimura T, Hamada N, Ban Y, Mori H, Momotani N, Takami H, Nishikawa Y, Ito K. Anterior pituitary, thyroid, parathyroid and adrenal responses to subtotal thyroidectomy in patients with Graves' disease. Jpn J Surg. 1982;12(4):235-243. . . 11) Yamamoto O, Takami H, Motomura Y, Miyata J, Hosoda Y, Mimura T, Ito K, Abe O. Polyamine levels and ornithine decarboxylase activities in human thyroid tumors. In: Ui N, Torizuka K (eds), Current problems in thyroid research. Amsterdam-Oxford-Princeton, Excerpta Medica, pp 533-536, 1983 . 12) Takami H, Umemoto S, Kodaira S, Ishibiki K, Abe,O. Antitumor effect of α-difluoromethyl ornithine (DFMO) and ornithine decarboxylase activity in a human tumor transplanted into nude mice. In: Imahori K, Suzuki F, Suzuki O & Bachrach U (eds), Polyamines: Basic and clinical aspects. Proceedings of a satellite symposium of the 3rd international congress on cell biology. Utrecht, VNU Science Press, pp 285-291, 1985 . 13)Taketa K, Ichikawa E, Akamatsu K, Ohta Y, Sekiya C, Namiki M, Takami H, Kaneda H, Higashino K, Taga H, Hirai H. Increased asialo-α-fetoprotein in patients withα-fetoprotein producing tumors: Demonstration by affinity electro- phoresis with erythroagglutinating phytohemagglutinin of Phaseolus vulgaris lectin. Tumor Biol. 1985;6(6):533-544. . 14) Mimura H, Hamana G, Ishitobi K, Momotani N, Ito K, Takami H. Graves' disease complicating pregnancy results of surgical treatment in 35 pregnancies. In: Vichayanrat A, Nitiyanant W, Eastman C, Nagataki S (eds), Recent progress in thyroidology. Bangkok, Crystal House Press, pp 483-486, 1987 . 15) Nakamura K, Kubo A, Hashimoto S, Furuuchi T, Takami H, Abe O. Radioimmunodetection of human pancreatic tumor xenografts using DU-PAN monoclonal antibody. Ann Nuclear Med. 1988;2(1):1-6. . . 16) Takami H, Bessho T, Kameya T, Mimura T, Ito K, Abe O, Hosoda Y, Shikata J. Immunohistochemical study of medullary thyroid carcinoma: Relationship of clinical features to prognostic factors in 36 patients. World J Surg. 1988;12(4):572-579. . 17) Ryusaki M, Konishi K, Kasuga A, Kumagai H, Suzuki H, Abe S, Saruta T, Takami H, Tashiro M. Spontaneous rupture of the quadriceps tendon in patients on maintenance hemodialysis-report of three cases with clinico- pathological observations. Clin Nephrol. 1989;32(3):144-148. . 18) Kakudo K, Takami H, Katayama S, Matsuura N, Kamoshida S, Miyauchi A, Watanabe K. Carcinoembryonic antigen and nonspecific cross-reacting antigen in medullary carcinoma of the thyroid. Acta Pathol Japonica. 1990;40(4):261-266. . 19) Takami H, Shikata J. Serum bone Gla proteins as an indicator of parathyroidectomy in patients with secondary hyperparathyroidism. World J Surg. 1990;14(3):431-436. . 20) Takami H, Shikata J, Horie H, Sekine K, Ito K. PDN-21: Possible tumor marker for medullary thyroid carcinoma. J Surg Oncol. 1990;44(4):205-207. . . 21) Takami H, Shikata J, Kakudo K, Ito K. Calcitonin gene-related peptide in patients with endocrine tumors. J Surg Oncol. 1990;43(1):28-32. . 22) Takami H, Shikata J. Graves' disease with severe iodine allergy: Successful surgery after lithium carbonate treatment. Eur J Surg. 1991;157(8):489-490. . 23) Takami H, Ito K. Calcitonin gene-related peptide as a tumor marker for medullary thyroid carcinoma. Int Surg. 1992;77(3):181-185. . 24) Miyaji S, Katakura K, Matsufuji S, Murakami Y, Hayashi S, Takami H, Oku Y, Okamoto M, Kamiya M. Polyamine metabolism in Taeniid Metacestodes. Jpn J Parasitol. 1992;41(4):327-333. . 25) Takami H, Kodaira S. A rapid immunoperoxidase method for pathological of occult thyroid carcinoma. Int Surg. 1993;78(3):225-228. . . 26) Takami H, Koudaira H, Kodaira S. Relationship of ornithine decarboxylase activity and human colon tumorigenesis. Jpn J Clin Oncol. 1994;24(3):141-143. . 27) Takami H, Kodaira S. Lithium in the surgical treatment of Graves' disease. Int Surg. 1994;79(1):89-90. . 29) Takami H, Kozakai M. Tuberculous thyroiditis: Report of a case with a review of the literature. Endocr J. 1994;41(6):743-747. . 30) Takami H. Clear cell carcinoma of the thyroid. Asian J Surg. 1995;18(3):241-243. . . 31) Taniguchi-Shirahama S, Koyama K, Miyauchi A, Wakasugi T, Oishi S, Takami H, Hikiji K, Nakamura Y. Germline mutation of the RET proto-oncogene in eight Japanese patients with multiple endocrine neoplasia type 2A(MEN2A). Hum Genet. 1995;95:187-190. . 32) Takami H, Takada T. Clinical utility of tumor markers in hepatocellular and pancreatic carcinomas. J Hep Bil Pancr Surg. 1995;2:395-400. . 33) Takami H, Kodaira S, Osamura Y. An immunohitochemical and flowcytometric study of gastroenterointestinal carcinoid tumors. J Exp Clin Cancer Res. 1995;14(4):401-407. . 34) Takami H, Ozaki O, Ito K. Familial nonmedullary thyroid cancer: An emerging entity that warrants aggressive treatment (Correspondence). Arch.Surg. 1996;131(6):676. . 35) Takami H, Kodaira S. Spermidine/spermine N1-acetyltransferase as a marker of dimethylhydrazine-induced colonic carcinogenesis in the rat. Oncol Rep. 1996;3(3):575-577. . . 36) Takami H, Satake S, Nakamura K, Kubo,A. Technetium 99m sestamibi is the useful procedure to locate parathyroid adenomas before surgery. Am J Surg. 1996;172(1):93. . 37) Takami H, Thosen T. Familial medullary thyroid carcinoma unassociated with multiple endocrine neoplasia. Thyroidol Clin Exp. 1996;8:9-14. . 38) Takami H. Current diagnosis and treatment of medullary thyroid carcinoma. Thyroidol Clin Exp. 1996;8:35-39. . 39) Takami H, Hosoda Y. Current status of multiple endocrine neoplasia in Japan. Oncol Rep. 1996;3:943-946. . 40) Takami H, Satake S, Nakamura K, Kubo A. What are the indications for 99mTc-sestamibi scintigraphy in hyperparathyroidism? Clin Endocrinol. 1996;45:121-122. . . . 41) Sugawara I, Satake S, Watanabe M, Nakamura K, Takami H, Kubo A, Akiyama S, Itoyama S. Tumor imaging of multidrug-resistant cancers with organotechnetium complex. Tumor Targeting. 1996;2:224-229. . 42) Takami H, Miyoshi H, Makuuchi H. Relationship between thyroid diseases and gastric lesions. Thyroidol Clin Exp. 1996;8:41-43. . 43) Makuuchi H, Takami H, Hamana G, Kameyama K, Nishi,T. Duodenal carcinoid tumor resected by strip biopsy. Oncol Rep. 1997;4:385-386. . 44) Kitamura Y, Goodfellow PJ, Shimizu K, Nagahama M, Ito K, Kitagawa W, Akasu H, Takami H, Tanaka S, Wells SA Jr. Novel germline RET proto-oncogene mutations associated with medullary thyroid carcinoma (MTC): Mutation analysis in Japanese patients with MTC. Oncogene. 1997;14:3103-3106. . 45) Takami H. Surgical management of hyperparathyroidism in view of a reliable parathyroid adenoma localization test. Surgery. 1997;122:120. . . 46) Satake S, Sugawara I, Watanabe M, Takami H. Lack of a point mutation of human DNA topoisomerase Ⅱin multidrug-resistant anaplastic thyroid cell lines. Cancer Lett. 1997;116:33-39. . 47) Takami H, Sekine M, Miyoshi H, Kodaira S, Ohgami M. Laparoscopic adrenalectomy in asymptomatic pheochromocytoma. Am Surgeon. 1997;63(9):820-822. . 48) Takada T, Takami H. Solitary splenic metastsis of a carcinoid tumor of the lung eight years postoperatively. J Srug Oncol. 1997;67(1):47-48. . 49) Sekine M, Takami H. Combination of calcitonin and pamidronate for emergency treatment of malignant hypercalcemia. Oncol Rep. 1997;5:197-199. . 50) Sekine M, Takami H, Satake S, Kodaira S, Sugiyama F. Treatment of skeletal and pulmonary metastases of differentiated thyroid carcinoma. Thyroidol Clin Exp. 1997;9(3):89-94. . . 51) Shan L, Kakudo K, Nakamura M, Nakamura Y, Yokoi T, Ishimoto J, Kawahara K, Takami H. Clonality of the parathyroid nodules with uremic parathyroid hyperplasia. Pathol Oncol Res. 1997;3(3):198-203. . 52) Kubo A, Nakamura K, Kawaguchi O, Satake S, Takami H. Successful Tc-99m MIBI imaging of recurrent hyperparathyroidism in parathyroid autotransplanted patients. Clin Nucl Med. 1997;22(12):872-874. . 53) Shirahama S, Ogura K, Takami H, Ito K, Tohsen T, Miyauchi A, Nakamura Y. Mutational analysis of the RET proto-oncogene in 71 Japanese patients with medullary thyroid carcinoma. J Hum Genet. 1998;43(2):101-106. . 54) Takami H, Ogino Y, Tanaka K, Kubo A. Somatostatin-receptor-negative carcinoid tumor responsible for Cushing’s syndrome. Eur J Surg Oncol. 1998;24:337-338. . 55) Takami H, Hayashi M, Konishi K, Maruyama H, Saruta T. Efficacy of combined use of calcitonin and bisphosphonate for the treatment of hypercalcemia. Intern Med. 1998;6(3):155-158. . . 56) Takami H. RET proto-oncogene mutation analysis for multiple endocrine neoplasia type 2. Arch Surg. 1998;133(6):679. . 57) Takami H, Miyoshi H, Makuuchi H. Strip biopsy for gastrointestinal carcinoid tumor. J Surg Oncol. 1998;68:60-61. . 58) Takami H, Thosen T, Shirahama S, Ogura K, Hikiji K. Does the syndrome of familial medullary thyroid carcinoma describe a distinct clinical entity? Eur J Cancer. 1998;34(10):1639-1640. . 59) Takami HE. Management of medullary thyroid carcinoma (Mini review). Thyroidol Clin Exp. 1998;10(2):59-65. . 60) Takami H, Kameyama K, Nagakubo I. Parathyroid carcinoma in a chronic hemodialysis patient. Surgery. 1999;125(2):239-240. . . 61) Takami H. Nationwide survey and analysis of the RET proto-oncogene in inherited medullary thyroid carcinoma in Japan. In: Utsunomiya J, Mulvihill JJ, Weber W (eds), Familial Cancer and Prevention. New York, Wiley-Liss, pp 371-375, 1999 . 62) Takami H, Niimi M, Ikeda Y. Prognosis of a family with familial medullary thyroid carcinoma. J Exp Clin Cancer Res. 1999;18(2):223-224. . 63) Takami H, Ikeda Y, Niimi M. Ultrasonically activated scalpel for subtotal thyroidectomy in Graves’ disease. Am J Surg. 1999;178(5):433-444. . 64) Kameyama K, Takami H. Pigmented granules in functional black adenoma of the adrenal gland a histochemical and ultrastructural study. Endocr Pathol. 1999;10(4):353-357. . 65) Takami H , Ikeda Y, Hayashi K, Hayashi M, Konishi K, Saruta T, Carpi A. Clinical assessment of collagen cross-linked N-telopeptides as a marker of bone metabolism in patients with primary hyperparathyroidism. Biomed Pharmacother. 1999;53(7):329-333. . . 66) Kameyama K, Takami H. DNA cytofluorometric analysis using HP/DAPI double staining of parathyroid carcinoma arising in a patient with chronic renal failure and secondary hyperparathyroidism. Oncol Rep. 1999;6:1345-1347. . 67) Takami H, Oshima M, Sugawara I, Satake S, Ikeda Y, Nakamura K. Kubo A. Pre-operative localization and tissue uptake study in parathyroid imaging with technetium-99m-sestamibi. ANZ J Surg. 1999;69:629-631. . 68) Kameyama K, Takami H. Schwannoma of the neck mimicking a thyroid tumor: a case report. Asian J Surg. 2000;23(2):175-176. . 69) Niimi M, Shirasugi N, Hamano K, Esato K, Matsumoto K, Ikeda Y, Shatari T, Takami H, Kodaira S. Oral delivery of xenoantigen combined with non-depleting anti-CD4 monoclonal antibody induced significant prolonged survival of concordant skin xenografts. Transplant Proc. 2000;32(5):1035. . 70) Takami H, Ikeda Y, Wada N. Surgical management of primary hyperparathyrodism. Biomed Pharmacother. 2000;54(Suppl 1):17-20. . . 71) Niimi M, Takashina M, Ikeda Y, Shirasugi N, Shatari T, Takami H, Kodaira S, Kameyama K, Matsumoto K, Hamano K, Esato K. Mice treated with Anti-CD4 monoclonal antibody accept fully allogeneic thyroid grafts but reject second-donor-type thyroid grafts in maintenance phase. Transplant Proc. 2000;32(7):2086. . 72) Takami H, Shirahama S, Ikeda Y, Sasaki Y, Wada N, Nimi M, Kameyama K. Familial hyperparathyrodism. Biomed Pharmacother. 2000;54(Suppl 1):21-24. . 73) Niimi M, Ikeda Y, Shirasugi N, Shatari T, Takami H, Kodaira S, Matsumoto K, Hamano K, Esato K, Wood KJ. The thymus is essential for the development of operational tolerance induced by donor-specific transfusion plus anti-CD4 monoclonal antibody. Transplant Proc. 2000;32(7):2067. . 74) Kameyama K, Takami H, Sanders D, Giordano TJ. Surgical pathology of hyperparathyroidism. Biomed & Pharmacother. 2000;54(Suppl 1):42-45. . 75) Niimi M, Ikeda Y, Shirasugi N, Shatari T, Takami H, Kodaira S, Matsumoto K, Hamano K, Esato K, Wood KJ. Intrathymic inoculation of donor B cells induced indefinite prolongation of fully allogeneic cardiac grafts but not islet or skin grafts. Transplant Proc. 2000;32:2020. . . 76) Ikeda Y, Takami H. Endoscopic parathyroidectomy. Biomed Pharmacother. 2000;54 (Suppl 1):52-56. . 77) Nimi M, Takashina M, Takami H, Shirasugi N, Hamano K, Esato K, Matsumoto K, Ikeda Y, Shatari T, Kodaira S. Kameyama K. Experimental parathyroid transplantation: human parathyroid grafts survived and functioned in mice treated with anti-CD4 monoclonal antibody. Biomed Pharmacother. 2000;54(Suppl 1):80-82. . 78) Hanatani Y, Kobayashi H, Kodaira S, Takami H, Asagoe T, Kaneshiro E. An in vitro chemosensitivity test for gastric cancer using collagen gel droplet embedded culture. Oncol Rep. 2000;7(5):1027-1033. . 79) Niimi M, Ikeda Y, Shirasugi N, Shatari T, Takami H, Kodaira S, Matsumoto K, Hamano K, Esato K, Hara M, Wood KJ. Oral delivery of alloantigen combined with non-depleting anti-CD4 monoclonal antibody induces indefinite survival of cardiac allografts and generates CD4(+) regulatory T cells. Transplant Proc. 2000;32(7):2035. . 80) Kameyama K, Takami H, Umemura S, Osamura YR, Wada N, Sugino K, Mimura T, Ito K. PCNA and Ki-67 as prognostic markers in human parathyroid carcinomas. Ann Surg Oncol. 2000;7(4):301-305. . . 81) Ikeda Y, Takami H, Sasaki Y, Kan S, Niimi M. Endoscopic neck surgery by the axillary approach. J Am Coll Surg. 2000;191(3):336-340. . 82) Niimi M, Takashina M, Shirasugi N, Hamano K, Esato K, Matsumoto K, Ikeda Y, Takami H, Kodaira S, Kameyama K. Human parathyroid grafts survived and functioned in mice treated with anti-CD4 monoclonal antibody. Transplant Proc. 2000;32(5):1040. . 83) Ikeda Y, Takami H, Sasaki Y, Kan S, Niimi M. Endoscopic resection of thyroid tumors by the axillary approach. J Cardiovasc Surg. 2000;41(5):791-792. . 84) Niimi M, Ikeda Y, Shirasugi N, Shatari T, Takami H, Kodaira S, Matsumoto K, Hamano K, Esato K, Hara M, Wood KJ. Oral administration of alloantigen plus nondepleting anti-CD4 monoclonal antibody induces indefinite prolongation of fully allogeneic cardiac allografts. Transplant Proc. 2000;32(2):259. . 85) Miyaki M, Iijima T, Ishi R, Hishima T, Mori T, Yoshinaga K, Takami H, Kuroi T, Iwama T. Molecular Evidence for Multicentric Development of Thyroid Carcinomas in Patients with Familial Adenomatous Polyposis. Am J Pathol. 2000;157(6):1825-1827 . . 86) Niimi M, Takashina M, Takami H, Ikeda Y, Shatari T, Hamano K, Esato K, Matsumoto K, Kameyama K, Kodaira S, Wood KJ. Overexpression of heme oxygenase-1 protects allogeneic thyroid grafts from rejection in naive mice. Surgery. 2000;128:910-917. . 87) Alsanea O, Wada N, Ain K, Wong M, Taylor K, Ituarte PHG, Treseler PA, Weier HU, Freimer N, Siperstein AE, Duh QY, Takami H, Clark OH. Is familial non-medullary thyriud carcinoma more aggressive than sporadic thyroid cancer? A multicenter series. Surgery. 2000;128(6):1043-1051. . 88) Shirasugi N, Matsumoto S, Hamano K, Esato K, Matsumoto K, Bashuda H, Yagita H, Okumura K, Ikeda Y, Takami H, Kodaira S, Niimi M. Survival of fully allogeneic cardiac allografts induced by delivery of alloantigen via respiratory mucosa is abrogated by blockade of the B7 pathway. Transplant Proc. 2000;32(7):2034. . 89) Ikeda Y, Niimi M, Sasaki Y, Shatari T, Takami H, Kodaira S. Thoracoscopic repair of a spontaneous perforation of the esophagus with the endoscopic suturing device. J Thorac Cardiovasc Surg. 2001;121(1):178-179. . 90) Takami H, Ikeda Y, Takayama J, Sasaki Y, Kan S, Niimi M, Inada E, Kameyama K. Adrenal-sparing adrenalectomy in hereditary bilateral pheochromocytoma. ANZ J Surg. 2001;71(10):623-624. . . 91) Ikeda Y, Takami H, Niimi M, Kan S, Sasaki Y, Takayama J. Laparoscopic partial or cortical-sparing adrenalectomy by dividing the adrenal central vein. Surg Endosc. 2001;15(7):747-750. . 92) Ikeda Y, Takami H, Niimi M, Kan S, Sasaki Y, Takayama J. Endoscopic thyroidectomy and parathyroidectomy by the axillary approach: a preliminary report. Surg Endosc 2001;16(1):92-95. . 93) Ikeda Y, Takami H, Niimi M, Kan S, Sasaki Y, Takayama J. Endoscopic total parathyroidectomy by the anterior chest approach for renal hyperparathyroidism. Surg Endosc. 2001;16(2):320-322. . 94) Shirasugi N, Ikeda Y, Akiyama Y, Matsumoto K, Hamano K, Esato K, Bashuda H, Yagita H, Okumura K, Takami H, Kodaitra S, Niimi M. Induction of hyporesponsiveness to fully allogeneic cardiac grafts by intratracheal delivery of alloantigen. Transplantation. 2001;71(4):561-564. . 95) Niimi M, Shirasugi N, Ikeda Y, Kan S, Takami H, Hamano K. Importance of thymus to maintain operational tolerance to fully allogeneic cardiac grafts. Ann Thorac Surg. 2001;72(3):735-739. . . 96) Ikeda Y, Niimi M, Kan S, Sasaki Y, Shatari T, Takami H, Kodaira S. Mediastinoscopic esophagectomy using carbon dioxide insufflation via the neck approach. Surgery. 2001;129(4):504-506. . 97) Kameyama K, Takami H, Miyajima K, Miura T, Hosoda Y, Ito K, Ito K. Papillary carcinoma occurring within an adenomatous goiter of thyroid gland in Cowden’s disease. Endocr Pathol. 2001;12(1):73-86. . 98) Niimi M, Shirasugi N, Ikeda Y, Kan S, Takami H, Hamano K. Operational tolerance induced by pretreatment with donor dendritic cells under blockade of CD40 pathway1. Transplantation. 2001;72(9):1556-1562. . 99) Niimi M, Takashina M, Shirasugi N, Hamano K, Esato K, Matsumoto K, Ikeda Y, Takami H, Kameyama K. Oral delivery of xeno-antigen combined with non-depleting Anti-CD4 monoclonal antibody induces significantly prolonged survival of concordant skin xenograft. Xenotransplantation. 2001;8(1):75-79. . 100) Ikeda Y, Takami H, Niimi M, Kan S, Sasaki Y, Takayama J. Endoscopic thyroidectomy by the axillary approach. Surg Endosc, 2001;15(11):1362-1364. . . 101) Ikeda Y, Niimi M, Kan S, Shatari T, Takami H, Kodaira S. Clinical significance of tissue blood flow during esophagectomy by laser Dopplerflowmetry. J Thorac Cardiovasc Surg. 2001;122(6):1101-1106. . 102) Shirasugi N, Akiyama Y, Ikeda Y, Kan S, Hamano K, Takami H, Kodaira S, Niimi M. Intratracheal delivery of alloantigen induces donor-specific hyporesponsiveness: dendritic cells play a pivotal role as regulatory cells. Transplant Proc. 2001;33(1-2):86. . 103) Shirasugi N, Ikeda Y, Akiyama Y, Matsumoto K, Hamano K, Esato K, Bashuda H, Yagita H, Okumura K, Takami H, Kodaitra S, Niimi M. Induction of hyporesponsiveness to fully allogeneic garafts by intratracheal delivery of alloantigen. Transplantation. 2001;71(4):561-564. . 104) Shirasugi N, Akiyama Y, Ikeda Y, Kan S, Hamano K, Takami H, Kodaira S, Niimi M. Intratracheal delivery of alloantigen induces donor-specific hyporesponsiveness: dendritic cells play a pivotal role as regulatory cells. Transplant Proc. 2001;33(1-2):86. . 105) Takami H, Ikeda Y. Endoscopic thyroidectomy via an axillary and anterior chest approach. In: Gagner M, Inabnet WB (eds), Minimally Invasive Endocrine Surgery, 1st ed. Philadelphia, Lippincott Williams & Wilkens Publishers, pp 55-63, 2002 . . 106) Takami H, Ikeda Y, Kan S, Kameyama K. New operative strategies in primary hyperparathyroidism. Asian J Surg. 2002;25(2):184-187. . 107) Ikeda Y, Niimi M, Kan S, Takami H, Kodaira S. Thoracoscopic Esophagectomy Combined with Mediastinoscopy via the Neck. Ann Thorac Surg. 2002;73(4):1329-1331. . 108) Kameyama K, Takami H. FAP associated thyroid carcinoma in mother and her daughter. Familial Cancer. 2001;1:83-86. . 109) Niimi M, Ikeda Y, Kan S, Takami H. Gas Gangrene in patient with atherosclerosis obliterans. Asian Cardiovasc Thorac Ann. 2002;10(2):178-180. . 110) Ikeda Y, Takami H, Sasaki Y, Takayama J, Kan S, Niimi M. Minimally invasive video-assisted thyroidectomy and lymphadenectomy for micropapillary carcinoma of the thyroid. J Surg Oncol. 2002;80:218-221. . . 111) Takami H, Ikeda Y. Minimally invasive thyroidectomy. ANZ J Surg. 72:841-842. . 112) Ikeda Y, Sasaki Y, Niimi M, Kan S, Takami H, kodaira S. Hand-assisted laparoscopic proximal gastrectomy with jejunal interposition and lymphadenectomy. J Am Coll Surg. 2002;195(4):578-581. . 113) Ikeda Y, Takami H, Sasaki Y, Takayama J, Kan S, Niimi M. Minimally invasive video-assisted thyroidectomy and lymphadenectomy for micropapillary carcinoma of the thyroid. J Surg Oncol. 2002;80:218-221. . 114) Takami HE, Kameyama K, Sano T, Kakudo K, Sasano H, Osamura R. Y. JEPS: Preface. Endocr Pathol. 2002;13:123. . 115) Sano T, Kovacs K, Asa SL, Yamada S, Sanno N, Yokoyama S, Takami H. Pituitary adenoma with “Honeycomb golgi” appearance showing a phenotypic change at recurrence from clinically nonfunctioning to typical Cushing disease. Endocr Pathol. 2002;13(2):125-130. . . 116) Kakudo K, Katoh R, Sakamoto A, Asa S,. DeLellis RA, Carney JA, Naganuma H, Kameyama K, Takami H. Thyroid gland: International case conference. Endocr Pathol. 2002;13(2):131-134. . 117) Kameyama K, DeLellis RA, Recardo V, Kakudo K, Takami HE. Parathyroid carcinomas: Can clinical outcomes parathyroid carcinomas be determined by histologic evaluation alone? Endocr Pathol. 2002;13(2):135-139. . 118) Sasano H, Suzuki T, Irie J, Kawai K, Aiba M, McNicol M, Takami H. Adrenal cortical diseases: International case conference. Endocr Pathol. 2002;13:141-148. . 119) Kumaki N, Kajiwara H, Kameyama K, Delellis RA, Asa SL, Osamura RY, Takami H. Prediction of malignant behavior of pheochromocytomas and paragangliomas using immunohistochemical techniques. Endocr Pathol. 2002;13:149-156. . 120) Takami HE. Minimally invasive endocrine surgery: Preface. Biomed Pharmacother. 2002;56: 3s. . . 121) Takami H. Parathyroid: Introduction. Biomed Pharmacother. 2002;56:5s-6s. . 122) Ikeda Y, Takami H, Tajima G, Sasaki Y, Takayama J, Kurihara H, Niimi M. Direct mini-incision parathyroidectomy. Biomed Pharmacother 2002;56:14s-17s. . 123) Ikeda Y, Takami H, Tajima G, Sasaki Y, Takayama J, Kurihara H, Niimi M. Total endoscopic parathyroidectomy. Biomed Pharmacother. 2002;56:22s-25s. . 124) Takami H, Sasaki Y, Ikeda Y, Tajima G. Intraoperative quick parathyroid hormone assay in the surgical management of hyperparathyroidism. Biomed Pharmacother. 2002;56:26s-30s. . 125) Takami H, Takayama J, Ikeda Y, Tajima G. Minimally invasive radioguided parathyroidectomy. Biomed Pharmacother. 2002;56:37s-40s. . . 126) Takami H. Thyroid: Introduction. Biomed Pharmacother. 2002;56:53s-54s. . 127) Ikeda Y, Takami H, Tajima G, Sasaki Y, Takayama J, Kurihara H, Niimi M. Direct mini-incision thyroidectomy. Biomed Pharmacother. 2002;56:60s-63s. . 128) Ikeda Y, Takami H, Tajima G, Sasaki Y, Takayama J, Kurihara H, Niimi M. Total endoscopic thyroidectomy: axillary or anterior chest approach. Biomed Pharmacother. 2002;56:72s-78s. . 129) Takami H, Sasaki K, Ikeda Y, Tajima G, Kameyama K. Sentinel lymph node biopsy in patients with thyroid carcinoma. Biomed Pharmacother. 2002;56:83s-87s. . 130) Ikeda Y, Takami H. Adrenal overview. Biomed Pharmacother. 2002;56:104s-106s. . . 131) Ikeda Y, Takami H, Tajima G, Sasaki Y, Takayama J, Kurihara H, Niimi M. Laparoscopic partial adrenalectomy. Biomed Pharmacother. 2002;56:126s-131s. . 132) Otani Y, Furukawa T, Suganuma K, Yoshida M, Saikawa Y, Kubota T, Kumai K, Mukai M, . 133) Ikeda Y, Takami H, Niimi M, Kan S. Sasaki Y. Takayama J. Endscopic total parathyroidectomy by the anterior chest approach for renal hyperparathyroidism. Surg Endosc. 2002;16:320-322. . 134) Ikeda Y, Takami H, Niimi M, Kan S, Sasaki Y. Takayama J. Endoscopic thyroidectomy and parathyroidectomy be the axillary approach. Surg Endosc. 2002;16:92-95. . 135) Ikeda Y, Takami H, Sasaki Y, Takayama J, Niimi M, Kan S. Comparative study of thyroidectomies. Endoscopic surgery versus conventional open surgery. Surg Endosc. 2002;16(12):1741-1745. . . 136) Niimi M, Ikeda Y, Kan S, Takami H. Superficialization of hemodialysis access using a video-assisted procedure. Surg Endosc. 2002;16(1):218. . 137) Niimi M, Ikeda Y, Kan S, Takami H, Furui S, Takeshita K. Spontaneous rupture of an intercostal artery due to neurofibromatosis type I disease treated by percutaneous embolization. Cardiovasc Intervent Radiol. 2002;25(2):160-161. . 138) Ikeda Y, Takami H, Sasaki Y, Takayama J, Niimi M. Kan S. Clinical benefits in endoscopic thyroidectomy by the axillary approach. J Am Coll Surg. 2003;196:189-195. . 139) Wada N, Duh QY, Sugino K, Iwasaki H, Kameyama K, Mimura T, Ito K, Takami H, Takanami Y. Lymph node metastasis from 259 papillary thyroid microcarcinoma: Frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg. 2003;237(3):399-407. . 140) Ikeda Y, Niimi M, Kan S, Shatari T, Takami H, Kodaira S. Conformal radiation therapy for liver metastasis of esophageal carcinoma. Hepatogastroenterology. 2003;50:532-534. . . 141) Takami H. Ikeda Y. Total endoscopic thyroidectomy. Asian J Surg. 2003;26:82-85. . 142) Ikeda Y, Takami H, Sasaki Y, Takayama J, Niimi M, Kan S. Is laparoscopic partial or cortical-sparing adrenalectomy worthwhile? Eur Surg. 2003;35(2):89-92. . 143) Kawabata W, Suzuki T, Moriya T, Fujimori K, Naganuma H, Inoue S, Kinouchi Y, Kameyama K, Takami H, Shimosegawa T, Sasano H. Estrogen receptors (alpha and beta) and 17betahydroxysteroid dehydrogenase type 1 and 2 in thyroid disorders:Possible in Situ estrogen synthesis and action. Modern pathlogy. 2003;16(5):437-444. . 144) Takami H. Medullary thyroid carcinoma and multiple endocrine neoplasia type 2. Endocr Pathol. 2003;14(2):123-132. . 145) Ikeda Y, Tobari S, Niimi M, Kan S, Takami H, Kodaira S. Reliable cervical anastomosis through the retrosternal route with stepwise gastric tube. J Thorac Cardiovasc Surg. 2003;125(6):1306-1312. . . 146) Takami H, Sasaki K, Ikeda Y, Tajima G, Kameyama K. Detection of sentinel lymph nodes in patients with papillary thyroid cancer. Asian J Surg. 2003;26(3):145-148. . 147) Ikeda Y, Niimi M, Takami H, Kodaira S. Successfully treated carcinoma erysipeloides from gastric cancer. Ann Oncol. 2003;14(8):1328-1329. . 148) Shirasugi N, AkiyamaY, Aramaki O, Shibutani S, Matsumoto K, Bashuda H, Yagita H, Okumura K, Ikeda Y, Niimi M, Kan S, Shatari T, Takami H, Kodaira S, Uchida N, Shimazu M, Kitajima M, Hamano K. Role of the CTLA4 pathway in hyporesponsiveness induced by intratracheal delivery of alloantigen. Transplantation. 2003;75(10):1636-1639. . 149）Takami H, Ikeda Y, Okinaga W, Kameyama K:Review:Recent advances in the management of primary hyperparathyroidism. Endocrine J. 2003;50(4):369-377. . 150）Kameyama K, Takami H. Double parathyroid carcinoma. Endocr J. 2003;50(4):477-479. . . 151) Seki T, Kameyama K, Hayashi H, Nagahama M, Masudo K, Fukunari N, Tanaka K, Sugino K, Ito K, Takami H. Composite metastatic carcinoma in lymph nodes of patients with concurrent medullary and papillary thyroid carcinoma: A report of two cases. Endocr Pathol. 2004;15(1):83-88. 152) Kameyama K, Takami H. Thyroid cancer in familial nomatous polyposis: A report of 14 cases. Internal Med. 2004;10:12-15. . 153) Tobari S, Ikeda Y, Kurihara H, Takami H, Okinaga K, Kodaira S. Effective treatment with chemotherapy and surgery for advanced small cell carcinoma of the esophagus. Hepato-Gastroenterol. 2004;51:1027-1029. . 154) Kameyama K, Okinaga H, Takami H. RET oncogene mutation in 75 cases of familial medullary thyroid carcinoma in Japan. Biomed Pharmacother. 2004;58:345-347. . 155) Kameyama K, Okinaga H, Takami H. Clinical manifestations of familial medullary thyroid carcinoma.Biomed Pharmacother. 2004;58:348-350. . 156) Takami H, Ikeda Y, Miyabe R, Okinaga H, Kameyama K, Fukunari N. Radiological and surgical management of thyroid neoplasms. Biomed Pharmacother. 2004;58:360-364. . 157) Kameyama K, Takami H. Medullary thyroid carcinoma: Nationwide Japanese survey of 634 cases in 1996 and 271 cases in 2002. Endocr J. 2004;51(5):453-456. . 158) Ikeda Y, Takami H, Sasaki Y, Takayama J, Kurihara H. Are there significant benefits of minimally invasive endoscopic thyroidectomy? World J Surg. 2004;28:1075-1078. . 159) Kameyama K, Mukai M, Takami H, Ito K. Cribriform-Morular variant of papillary thyroid carcinoma: Ultrastructural study and somatic/germline mutation analysis of the APC gene. Ultrastruct Pathol. 2004;28:97-102. . 160) Tamura Y, Okinaga H, Takami H. Glucocorticoid-induced osteoporosis. Biomed Pharmacother. 2004;58:500-504. . 161) Ikeda Y, Tajima G, Miyabe R, Takayama J, Takami H, Okinaga K. Cervical excision using superior sternum lifting method for large mediastinal parathyroid gland. J Surg Oncol. 2005;89: 265-267. . 162) Shigematsu N, Takami H, Ito N, Kubo A. Nationwide survey on the treatment policy for well-differentiated thyroid cancer -Results of a questionnaire distributed at the 37th meeting of the Japanese society of thyroid surgery. Endocr J. 2005;52(4):479-491. . 163) Kameyama K, Takami H. Proposal for the histological classification of parathyroid carcinoma. Endocr Pathol. 2005;16(1):49-52. . 164) Neumann HP, Cybulla M, Shibata H, Oya M, Naruse M, Higashihara E, Terachi T, Ling H, Takami H, Shuin T, Murai M. New genetic causes of pheochromocytoma: current concepts and the clinical relevance. Keio J Med. 2005;54(1):15-21. . 165) Tobari S, Ikeda Y, Takami H. Beneficial Effects of Intravenous Administration of Lipo-Prostaglandin E1 on the Ischemic Gastric Tube in Pigs. J Surg Res. 2005;55:79-84. . 166) Takami H. Hypercalcemic crisis, In: Textbook of endocrine surgery, 2nd edition, eds. by O. Clark, Q-Y Duh and E Kebebew. Elsevier Saunders, Philadelphia. 2005;pp543-548. . 167) Sakurai A, Uchino S, Takami H. Current status of clinical for familial endocrine tumor syndromes in Japan. Endocr J. 2005;52(6):757-762. . 168) Takami H, Ikeda Y. Minimally invasive thyroidectomy. Curr Opin Oncol. 2006;18(1):43-47. . 169) Sugino K, Ito K, Takami H. Management of differentiated thyroid carcinoma with radioiodine and recombinant human TSH. Endocr J. 2006(in press) . 170) Shigematsu N, Takami H, Kubo A. Unique treatment policy for well-differentiated thyroid cancer in Japan -Results of a questionnaire distributed to members of the Japanese Society of Thyroid Surgery and International Association of Endocrine Surgeons-. Endocr J. 2006(in press) . 171) Takami H. Hashimoto’s disease and Dr. Hakaru Hashimoto. World J Surg (in press) . 172) Ikeda Y, Kurihara H, Morita N, Miyabe R, Takami H. Significance of monitoring bio-intact PTH(1-84)during parathyroidectomy for secondary hyperparathyroidism. J Surg Res.2007,139:83-87. 173) Ikeda Y, Kurihara H, Morita N, Miyabe R, Takami H. The Role of quick bio-intact PTH(1-84)assay during parathyroidectomy for secondary hyperparathyroidism, J Surg Res.2007,141:306-310. 174) Sugino K, Ito K, Takami H. Management of differentiated thyroid carcinoma with radioiodine and recombinant human TSH.Endocrine J Surg.2006, 53(6):723-728. . .. . . |
